Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
API
More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand…
Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories
NPPA rejects IPA request for upward price revision of five per cent on all drugs
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19…
Ipca Labs is setting up API manufacturing facility in Dewas, MP
It is in the process of procuring environmental clearance for the new plant which is being built with an initial capital outlay of…
Ajinomoto Bio-Pharma expands small molecule manufacturing capabilities in India
The new 8,500 sq metre facility in Visakhapatnam is expected to be completed mid-2022
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers
FDI in pharma and related implications of COVID-19
Arvind Sharma, Partner - M&A and General Corporate, Shardul Amarchand Mangaldas & Co states that the pharma sector is well…
DoP to finalise guidelines to select locations of three bulk drug parks and four med devices parks:…
Govt of Punjab shows interest in extending support for the development of bulk drugs park in the State
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage:…
The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or…
Pharma industry requests time-bound amendments in DPCO 2013
The industry specifically appealed for amendments in Para 13 (2) and Para 15 (6) of DPCO 2013 to overcome the challenge of surging…